
Satwinder Singh
About Satwinder Singh
Data last updated:
Satwinder Singh is a Director at Akums Drugs And Pharmaceuticals Limited (since 2024), Director at Pure And Cure Healthcare Private Limited (since 2025) and Director at Ds (Assam) Hospitality Limited (since 2022), and holds 1 more current directorship. The companies operate in Chemicals, Pharma and Travel and Hospitality. The 4 current companies with reported revenue have a combined latest revenue of ₹6,385 Cr; the largest is Akums Drugs And Pharmaceuticals Limited at ₹4,488 Cr (FY 2026). Earlier, Satwinder Singh was a Designated Partner at Grace Realcon Llp (2015–2016) and Designated Partner at Corporatecare Consultants Llp (2015–2016) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Jan 2024 | 2004 | ₹4,488 Cr (FY 2026) | Active | |
| Director | 03 Feb 2025 | 2005 | ₹1,781 Cr (FY 2026) | Active | |
| Director | 01 Feb 2022 | 2007 | ₹110 Cr (FY 2025) | Active | |
| Director | 01 Feb 2022 | 2010 | ₹6.57 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 14 Feb 2015 | 2015 | Strike Off | ||
| Designated Partner | 17 Feb 2015 | 2015 | Active | ||
| Director | 29 Sep 2012 | 1990 | ₹12,307 Cr (FY 2026) | Active | |
| Additional Director | 31 Mar 2015 | 2006 | ₹1,066 Cr (FY 2025) | Active | |
| Director | 14 Sep 2018 | 2001 | Active | ||
| Director | 21 Aug 2019 | 2004 | ₹308 Cr (FY 2024) | Amalgamated | |
| Director | 29 Dec 2011 | 2008 | ₹116 Cr (FY 2025) | Active | |
| Director | 16 Sep 2019 | 1965 | ₹453 Cr (FY 2025) | Active | |
| Designated Partner | 17 Jul 2017 | 2017 | Strike Off | ||
| Director | 19 May 2010 | 2010 | Converted To Llp | ||
| Director | 27 Dec 2006 | 2006 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satwinder Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satwinder Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satwinder Singh
Satwinder Singh currently holds 4 directorships: Akums Drugs And Pharmaceuticals Limited (Director, since 17 Jan 2024, revenue ₹4,488 Cr (FY 2026)); Pure And Cure Healthcare Private Limited (Director, since 03 Feb 2025, revenue ₹1,781 Cr (FY 2026)); Ds (Assam) Hospitality Limited (Director, since 01 Feb 2022, revenue ₹110 Cr (FY 2025)); Seven R Hotels Private Limited (Director, since 01 Feb 2022, revenue ₹6.57 Cr (FY 2025)).
Satwinder Singh was first appointed on 27 Dec 2006 as Director at Corporatecare Consultants Private Limited. The most recent appointment on record is 03 Feb 2025 at Pure And Cure Healthcare Private Limited.
The 4 current companies of Satwinder Singh that report revenue have a combined latest revenue of ₹6,385 Cr: Akums Drugs And Pharmaceuticals Limited ₹4,488 Cr (FY 2026); Pure And Cure Healthcare Private Limited ₹1,781 Cr (FY 2026); Ds (Assam) Hospitality Limited ₹110 Cr (FY 2025); Seven R Hotels Private Limited ₹6.57 Cr (FY 2025).
Satwinder Singh held 13 earlier board appointments: Grace Realcon Llp (Designated Partner, 14 Feb 2015 to 26 Sep 2016); Corporatecare Consultants Llp (Designated Partner, 17 Feb 2015 to 26 Sep 2016); Amber Enterprises India Limited (Director, 29 Sep 2012 to 12 Jan 2017); Continental India Private Limited (Additional Director, 31 Mar 2015 to 06 Nov 2015); Il Jin Electronics (India) Private Limited (Director, 14 Sep 2018 to 13 May 2022); and 8 more.
The current boards of Satwinder Singh's companies include Anilkumar Arvindlal Amin (Akums Drugs And Pharmaceuticals Limited), Dharamvir Malik (Akums Drugs And Pharmaceuticals Limited), Kewal Kundanlal Handa (Akums Drugs And Pharmaceuticals Limited), Matangi Gowrishankar (Akums Drugs And Pharmaceuticals Limited), Sandeep Jain (Akums Drugs And Pharmaceuticals Limited), Sanjay Sinha (Akums Drugs And Pharmaceuticals Limited), among others.